Maravai Lifesciences Holdings (MRVI) FCF Margin (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly FCF Margin came in at 6.42% in Q1 2026, up 2953.0% year-on-year from 0.21% in Q1 2025, and up 109.15% quarter-over-quarter from 70.19% in Q4 2025.
Maravai Lifesciences Holdings (MRVI) FCF Margin (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' FCF Margin history runs 7 years deep, the most recent figure standing at 6.42% for Q1 2026.
- On a quarterly basis, FCF Margin rose 2953.0% year-over-year to 6.42% in Q1 2026; TTM through Mar 2026 was 27.19%, a 2953.0% decrease from a year earlier, with the FY2025 full-year figure at 38.08%, down 3995.0% from the prior year.
- FCF Margin climbed to 6.42% in Q1 2026 per MRVI's latest filing, from 70.19% in the prior quarter.
- Across five years, FCF Margin topped out at 97.7% in Q1 2023 and bottomed at 70.19% in Q4 2025.
- The 5-year median for FCF Margin is 6.58% (2024), against an average of 15.64%.
- Across the five-year window, FCF Margin surged 4068 bps in 2022 and tumbled 11582 bps in 2024, its largest moves.
- Year by year, FCF Margin stood at 53.01% in 2022, then soared by 39 bps to 73.55% in 2023, then plunged by 84 bps to 11.59% in 2024, then plunged by 706 bps to 70.19% in 2025, then jumped by 109 bps to 6.42% in 2026.
- Per Business Quant, the three latest MRVI FCF Margin figures stand at 6.42% (Q1 2026), 70.19% (Q4 2025), and 19.11% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn | 6.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42% |
| Dec 31, 2025 | -70.19% |
| Sep 30, 2025 | -19.11% |
| Jun 30, 2025 | -35.74% |
| Mar 31, 2025 | -23.10% |
| Dec 31, 2024 | 11.59% |
| Sep 30, 2024 | 6.58% |
| Jun 30, 2024 | 7.75% |
| Mar 31, 2024 | -18.12% |
| Dec 31, 2023 | 73.55% |
| Sep 30, 2023 | -2.48% |
| Jun 30, 2023 | -8.51% |
| Mar 31, 2023 | 97.70% |
| Dec 31, 2022 | 53.01% |
| Sep 30, 2022 | 54.16% |
| Jun 30, 2022 | 66.58% |
| Mar 31, 2022 | 65.73% |
| Dec 31, 2021 | 28.80% |
| Sep 30, 2021 | 47.56% |
| Jun 30, 2021 | 76.27% |